- $119.28m
- $149.76m
- $248.97m
Annual income statement for Eastern, fiscal year end - January 3rd, USD millions except per share, conversion factor applied.
2022 December 31st | 2022 January 1st | R2023 December 30th | 2024 December 28th | 2026 January 3rd | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 279 | 247 | 259 | 273 | 249 |
| Cost of Revenue | |||||
| Gross Profit | 58.6 | 56.8 | 61.8 | 69.8 | 67.2 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 265 | 229 | 242 | 253 | 238 |
| Operating Profit | 14.2 | 17.4 | 17 | 20.1 | 10.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 14.4 | 19.1 | 15.1 | 17.1 | 7.49 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 11.1 | 16.2 | 12.7 | 13.2 | 5.97 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 12.3 | 9.35 | 8.59 | -8.53 | 7.13 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 12.3 | 9.35 | 8.59 | -8.53 | 7.13 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.86 | 2.83 | 2.02 | 2.44 | 3.25 |
| Dividends per Share |